1 Schwab R, Lim R, Goldberg R. Resolving intestinal fibrosis through regenerative medicine. Curr Opin Pharmacol. 2019;49:90-94.
2 Lenti MV, Di Sabatino A. Intestinal fibrosis. Mol Aspects Med. 2019;65:100-109.
3 Rieder F, Latella G, Magro F, Yuksel ES, Higgins PD, Di Sabatino A, et al. European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease. J Crohns Colitis. 2016;10(8):873-885.
4 Di Sabatino A, Lenti MV, Giuffrida P, Vanoli A, Corazza GR. New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract. Autoimmun Rev. 2015;14(12):1161-1169.
5 Wirtz S, Popp V, Kindermann M. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017;12(7):1295-1309.
6 Latella G, Papi C. Crucial steps in the natural history of inflammatory bowel disease. World J Gastroenterol. 2012;18(29):3790-3799
7 Lakatos G, Hritz I, Varga MZ, Juhász M, Miheller P, Cierny G, et al. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases. Dig Dis. 2012;30(3):289-295.
8 Rieder F, Fiocchi C, Rogler G. Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases. Gastroenterology. 2017;152(2):340-350.
9 Latella G, Di Gregorio J, Flati V, Rieder F, Lawrance IC. Mechanisms of initiation and progression of intestinal fibrosis in IBD. Scand J Gastroenterol. 2015;50(1):53-65.
10 Speca S, Giusti I, Rieder F, Latella G. Cellular and molecular mechanisms of intestinal fibrosis. World J Gastroenterol. 2012;18(28):3635-3661.
11 Wang J, Wong YK, Liao F. What has traditional Chinese medicine delivered for modern medicine? Expert Rev Mol Med. 2018;20:e4.
12 Chen Z, Hu Y, Li J, Zhang C, Gao F, Ma X, et al. A feasible biocompatible hydrogel film embedding Periplaneta americana extract for acute wound healing. Int J Pharm. 2019;571:118707.
13 Zhu JJ, Yao S, Guo X, Yue BS, Ma XY, Li J. Bioactivity-Guided Screening of Wound-Healing Active Constituents from American Cockroach (Periplaneta americana). Molecules. 2018;23(1):101.
14Zhao Y, Yang A, Tu P, Hu Z. Anti-tumor effects of the American cockroach. Periplaneta americana. Chin Med. 2017;12:26.
15 Li D, Li W, Chen Y, Liu L, Ma D, Wang H, et al. Anti-fibrotic role and mechanism of Periplaneta americana extracts in CCl4-induced hepatic fibrosis in rats. Acta Biochim Biophys Sin (Shanghai). 2018;50(5):491-498.
16 Liu J, Zhou L, He L, Zhong Y, Zhang X, Xiao B, Liu G. Periplaneta americana extract may attenuate renal fibrosis through inhibiting janus tyrosine kinase 2/signal transducer and activator of transcription 3 pathway. 2018; 102: 1-8.
17 Yao H, Wei S, Xiang Y, Wu Z, Liu W, Wang B, et al. Kangfuxin Oral Liquid Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1/Smad Pathway. Evid Based Complement Alternat Med. 2019;2019:5124026.
18 Li W, Duan LF, He GQ, Liang YP, Zhang YF, Yang HQ, et al. Prevention of cc14-induced liver fibrosis by periplaneta americana extract. Zhonghua Gan Zang Bing Za Zhi 2009;17: 948–950.
19 Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, Neurath MF. Chemically induced mouse models of acute and chronic intestinal inflammation. 2017; 12: 1295-1309.
20 Kiesler P, Fuss IJ, Strober W. Experimental Models of Inflammatory Bowel Diseases. Cell Mol Gastroenterol Hepatol. 2015;1(2):154-170.
21 Bettenworth D, Rieder F. Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication. Dig Dis. 2017;35(1-2):25-31.
22 Lawrance IC, Rogler G, Bamias G, Breynaert C, Florholmen J, Pellino G, et al. Cellular and Molecular Mediators of Intestinal Fibrosis. J Crohns Colitis. 2017;11(12):1491-1503.
23 Roulis M, Flavell RA. Fibroblasts and myofibroblasts of the intestinal lamina propria in physiology and disease. Differentiation. 2016;92(3):116-131.
24 Kunovsky L, Kala Z, Marek F, Dolina J, Poredska K, Kucerova L, et al. The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn's disease. Int J Colorectal Dis. 2019;34(2):347-351.
25 Leask, A., Abraham, D.J., 2004. TGF-beta signaling and the fifibrotic response. FASEB. J. 18 (7), 816–827.
26 Walton KL, Johnson KE, Harrison CA. Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis. Front Pharmacol. 2017;8:461.
27 Latella G, Sferra R, Speca S, Vetuschi A, Gaudio E. Can we prevent, reduce or reverse intestinal fibrosis in IBD?. Eur Rev Med Pharmacol Sci. 2013;17(10):1283-1304.
28 Yun SM, Kim SH, Kim EH. The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review. Front Pharmacol. 2019;10:162.
29 Sabatino AD, Jackson CL, Pickard KM, Buckley M, Gut SLFPJ. Transforming growth factor β signalling and matrix metalloproteinases in the mucosa overlying crohn's disease strictures. 2009; 58: 777-789.
30 Zhang HJ, Zhang YN, Zhou H, Guan L, Li Y, Sun MJ. Il-17a promotes initiation and